Beneficial Effects of Swertiamarin on Dyslipidaemia in Streptozotocin-induced Type 2 Diabetic Rats
Beneficial Effects of Swertiamarin on Dyslipidaemia in Streptozotocin-induced Type 2 Diabetic Rats
复制标题
DOI:
10.1002/ptr.3708
复制
发表时间:
2012-08-01
影响因子:
7.2
通讯作者:
Goyal, Ramesh K.
中科院分区:
文献类型:
--
作者:
Vaidya, Hitesh;Prajapati, Alpesh;Goyal, Ramesh K.
Dyslipidaemia is one of the major risk factors for cardiovascular disease in diabetes mellitus. Lipid changes associated with diabetes mellitus are attributed to increases in free fatty acid flux, secondary to insulin resistance. In the present study, we have investigated the beneficial effects of swertiamarin on dyslipidaemic conditions associated with type 2 diabetes in streptozotocin-induced type 2 diabetic rats. Swertiamarin (50?mg/kg, i.p.) administered once a day for 6?weeks resulted in significant (p?